Edwards Lifesciences Corporation Common Stock vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.16 (market cap $4.39B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 11.1× State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.
| EW | SJNK | |
|---|---|---|
Market Cap | $48.56B | $4.39B |
Volume | 6,520,488 | 2,606,488 |
Sector | Health | Fixed Income |
52-Week High | $95.18 | $25.57 |
52-Week Low | $72.65 | $24.13 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 40 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SJNK (SPDR Bloomberg Short Term High Yield Bond ETF) trades at $24.20, down 0.21% with bearish technical signals from moving averages. The ETF shows neutral oscillator readings with RSI indicating potential oversold conditions. Recent institutional activity includes Cetera Investment Advisers reducing its position by 9.4% to 713,936 shares as of July 2026. Dividend distributions continue with recent payments of $0.14-$0.15 per share.
The ETF faces headwinds from high-yield bond market volatility while offering nearly double the yield of Treasuries. Key risks include interest rate sensitivity and credit quality concerns in the underlying bond portfolio. Current technical weakness suggests cautious near-term outlook despite attractive income potential for yield-seeking investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →